Introduction: Kalanchoe pinnata and Salvia rosmarinus are rich sources of bioactive compounds with documented anti‑inflammatory and antioxidant activities. However, the combined bioactivity of these extracts and their preformulation properties for pharmaceutical development remain underexplored. We investigated whether combining crude ethanolic extracts would yield enhanced anti‑inflammatory and antioxidant activities compared to individual extracts, and assessed their physicochemical suitability for formulation.
Methods: Dried leaf powders were extracted by cold maceration in 70% ethanol. Extracts were screened for phytochemical classes using standard tests. Anti‑inflammatory activity was measured via protein denaturation and antiproteinase assays (prednisolone control), and antioxidant activity via DPPH radical scavenging (ascorbic acid control). Preformulation characterisation included organoleptic properties, bulk density, flow indices, solubility, and partition coefficient.
Results: Both extracts contained flavonoids, phenols, tannins, and saponins. The combined extract exhibited dose‑dependent anti‑inflammatory activity superior to individual extracts (antiproteinase IC₅₀ 192.99 µg/mL; protein inhibition IC₅₀ 71.43 µg/mL). Its antioxidant activity (IC₅₀ 101.63 µg/mL) was comparable to that of ascorbic acid (159.13 µg/mL). Preformulation evaluation showed excellent flow properties (Carr’s Index <10%), solubility in polar solvents, and oxidative stability.
Conclusions: The combined K. pinnata and S. rosmarinus extracts demonstrate enhanced anti‑inflammatory and antioxidant activities relative to single extracts, suggesting potential additive or synergistic interactions. Favourable preformulation characteristics support further development as a botanical therapeutic. Limitations include the in vitro nature of bioactivity assays, lack of active constituent quantification, and the need for in vivo efficacy and stability studies.